Health Condition 1: null- patients with Type 2 diabetes with peripheral neuropathic pain Health Condition 2: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Intervention1: Low level laser therapy: The study group will be treated with two separate low level laser (heliumâ??neon laser), ie, the EC laser wavelength of 632.8 nm with dosage of 3.1 J/cm2 and T
Sponsors
Self
Eligibility
Inclusion criteria
Inclusion criteria: 1. People of age 30-70 years 2. Type II Diabetes mellitus with peripheral neuropathic pain 3. Those who are willing to provide informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with any other neurological disorder or morbid conditions 2. Patients with other metabolic Neuropathy ( e.g.: Thyroid disorders) 3. Pregnant women 4. Patients undergoing chemotherapy and radiation 5. Patients with DPN with foot ulcer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| variations in biomarkers level after the low level laser therapyTimepoint: Baseline sample will be collected on 1st day before starting laser therapy. 2nd sample will be collected on 30th day from last day of laser treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| variation in gene expressionTimepoint: Changes in gene expression, 4 weeks after treating with low level laser | — |
Countries
India
Contacts
Public ContactAnju M
School of Allied Health Sciences
Outcome results
None listed